Celastrol

Celastrol has attracted extraordinary research attention — over 1,000 publications as of 2024 — as a multi-target natural compound with potential in cancer, neurodegeneration, obesity, and autoimmune disease. A landmark 2015 Nature paper demonstrated dramatic weight loss in obese mice via leptin sensitisation. Human data are limited to traditional use; pharmacokinetic challenges (poor water solubility, extensive first-pass metabolism) have hampered clinical translation. Significant anti-inflammatory and analgesic effects in animal models of rheumatoid arthritis strongly support chuchuhuasi's traditional anti-rheumatic indication.

Celastrol is a secondary bioactive in thunder god vine with strong anti-inflammatory properties documented in preclinical and clinical studies for autoimmune arthritis. More selective than triptolide for inflammation while showing reduced acute toxicity, though long-term safety requires monitoring.